Urgent.ly (ULY) director reports 900-share sale under 10b5-1 trading plan
Rhea-AI Filing Summary
Urgent.ly Inc. director Ben Volkow reported two sales of the issuer's common stock under a Rule 10b5-1 trading plan. On 08/18/2025 he sold 300 shares at a weighted-average price of $4.9307, reducing his direct holdings to 16,349 shares. On 08/19/2025 he sold 600 shares at a weighted-average price of $4.7812, bringing his direct holdings to 15,749 shares. The filing states the sales were effected under a 10b5-1 plan adopted on November 20, 2023, and notes the reported prices are weighted averages from multiple transactions within disclosed ranges.
Positive
- Sales executed under a Rule 10b5-1 plan, indicating trades were pre-authorized and reducing concerns about opportunistic insider timing
- Reporting transparency: filing provides weighted-average prices and an undertaking to supply per-price execution details on request
Negative
- Insider sold 900 shares over two days, reducing holdings from 16,349 to 15,749 shares (materiality appears limited but is a net reduction in insider ownership)
Insights
TL;DR: Director sold a small portion of holdings through a pre-established 10b5-1 plan; transactions appear routine and orderly.
The transactions consist of 900 shares sold across two days via a Rule 10b5-1 trading plan adopted on November 20, 2023. The use of a 10b5-1 plan signals the trades were pre-authorized, reducing likelihood of opportunistic timing by the insider. The weighted-average prices reported ($4.9307 and $4.7812) reflect multiple executions within disclosed price ranges. The remaining direct share count after the second sale is 15,749 shares. From an investor-materiality standpoint, the size of the sales relative to reported holdings is small and does not indicate a change in control or major shift in insider exposure.
TL;DR: Governance signal is neutral: sales were executed under an established 10b5-1 plan, which provides procedural transparency.
The filing explicitly states the trades were made pursuant to a Rule 10b5-1 plan and provides weighted-average pricing ranges for the multiple executions. The reporting includes an undertaking to provide detailed per-price execution information upon request, which supports disclosure completeness. No executive departure, new grants, or other governance actions are disclosed in this Form 4. The filing appears compliant and routine from a governance disclosure perspective.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 600 | $4.7812 | $3K |
| Sale | Common Stock | 300 | $4.9307 | $1K |
Footnotes (1)
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 20, 2023. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $5.06, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.96, inclusive.
